Applied Nanotech Financial Statements
Applied Nanotech Financial Information
| Company Type | Public |
|---|---|
| Fiscal Year-End | December |
| Annual Report | Company Web Site |
Applied Nanotech Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 4.0 | 1.1 | 0.6 |
| Gross Profit ($ mil.) | -- | -- | -- |
| Operating Income ($ mil.) | (4.4) | (6.6) | (4.7) |
| Total Net Income ($ mil.) | (4.3) | (6.6) | (4.7) |
| Diluted EPS (Net Income) | (0.04) | (0.07) | (0.05) |
Applied Nanotech Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 10.62 | 0.76 | 1.04 |
| Price/Earnings Ratio | -- | 10.87 | 11.02 |
| Price/Book Ratio | 35.85 | 1.00 | 0.99 |
| Price/Cash Flow Ratio | -- | 7.77 | 6.42 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Applied Nanotech Financial Ratios
Applied Nanotech Competitive Intelligence
| Nanomix | Unidym | Zyvex | |
|---|---|---|---|
| Annual Sales ($ mil.) | 2.1 | 1.4 | 10.0 |
| Employees | 20 | 25 | 60 |
| Market Cap ($ mil.) | -- | -- | -- |
Competitive Landscape





